Resources

Videos for clinicians to learn more about Arthrosamid®, a new class of injectable therapy to treat knee osteoarthritis patients.

If you cannot find the content you need here, please contact us.

Contact the team

Clinical information Brochures / Leaflets Videos FAQs

0:15

BASK 2023 Congress - Introducing Arthrosamid^® a new class of injectable therapy to treat knee osteoarhritis

_{The team attended the BASK 2023 Congress to discuss a new injectable class of therapy to treat patients with knee osteoarthritis.}

_{Arthrosamid® is a new type of treatment injected into the knee to help treat the pain caused by knee osteoarthritis, offering an alternative to currently available therapies.}

_{A recent study presented at OARSI 2023 World Congress has demonstrated that a single injection of 6 ml 2.5% polyacrylamide #hydrogel, Arthrosamid®, maintained a statistically significant reduction in pain in patients with knee osteoarthritis (OA) 3 years after treatment.}

Arthrosamid Event Follow Up October 2022

0:35

BOA 2022 Congress and London Knee Meeting Summary

We attended the BOA2022 Congress and London Knee Meeting this month to introduce Arthrosamid®, a new class of therapy for patients with knee osteoarthritis. the coming month, we will attend the Bristol/Oxford Uni Knee Meeting and Wexham Cruciate 2022.

BASK 2022 Conference Arthrosamy by Contura Orthopaedics

0:30

BASK 2022 - Introducing Arthrosamid^®, a new class of injectable therapy to treat knee OA

Safe and sustained pain relief with a single injection. A novel treatment for adults with knee osteoarthritis.

0:15

BASK 2022 - Introducing Arthrosamid^®, a new class of injectable therapy to treat knee OA

Arthrosamid® by Contura Orthopaedics is an intra-articular polyacrylamide hydrogel injection (iPAAG). It is a non-biodegradable single-dose injection that delivers long-acting and sustained pain relief, improving the quality of life for patients with knee osteoarthritis.

ESSKA 2022 Arthrosamid by Contura Orrthopaedics

1:30

ESSKA 2022 - Introducing Arthrosamid^®, a new class of injectable therapy to treat knee OA